Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Go back to Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
(NYSE: MTNB) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High $2.01 
Open $0.66    52 Week Low $0.41 
Day High $0.67    P/E N/A 
Day Low $0.66    EPS $0.00 
Volume 19,948